Trump Touts Lilly’s $4.5 Billion Investment in US Facilities

Eli Lilly & Co. is spending another $4.5 billion on its manufacturing plants in Indiana and drawing the attention of President Donald Trump as the drugmaker shores up its domestic supply chain.

The investment will go toward technology enhancements at Lilly’s first dedicated genetic medicine facility, which opened Wednesday, the company said in a statement on Wednesday. It will also support a future facility opening in 2027 that will become the nation’s largest production site for active pharmaceutical ingredients. Both are located in Lebanon, about 27 miles northwest of Indianapolis, where Lilly is based.